The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
申请公布号
CA2761241(A1)
申请公布日期
2010.11.11
申请号
CA20102761241
申请日期
2010.05.07
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
CHEN, CHI-LI;CLARK, ROGER B.;DENG, YONGHONG;HE, MINSHENG;PLAMONDON, LOUIS;SUN, CUIXIANG;XIAO, XIAO-YI;ROENN, MAGNUS
